Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: Long term results of the EORTC CLG 58881 trial. (2008)
UYTTEBROECK, A,
SUCIU, S,
Laureys, Genevieve,
PAQUEMENT, H,
FERSTER, A,
MARGUERITTE, G,
...
Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q(10) deficiency (2007)
AEBY, A,
SZNAJER, Y,
CAVÉ, H,
REBUFFAT, E,
Van Coster, Rudy,
RIGAL, O,
...
Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCR beta-HOXA rearrangement: a study of the Groupe Francophone de Cytogenetique Hematologique (2007)
Cauwelier, Barbara,
CAVÉ, H,
GERVAIS, C,
LESSARD, M,
BARIN, C,
PEROT, C,
...
The TCRB-HOXA rearrangement in T-ALL leads to a specific increase of the alternative HOXA10b transcript (2006)
Cauwelier, Barbara,
CAVÉ, H,
DASTUGUE, N,
HEIMANN, P,
ANTOINE-POIREL, H,
Verhasselt, Bruno,
...
Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951 (2004)
CAVÉ, H,
SUCIU, S,
PREUDHOMME, C,
Poppe, Bruce,
ROBERT, A,
UYTTEBROECK, A,
...
PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience (2004)
KEREN, B,
HADCHOUEL, A,
SABA, S,
SZNAJER, Y,
BONNEAU, D,
LEHEUP, B,
...
t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Francais de Cytogenetique Hematologique (GFCH) (2003)
BERGER, R,
DASTUGUE, N,
BUSSON, M,
PEROT, C,
BALLERINI, P,
...
HOX11L2 expression linked to t(5;14)(q35;q32) is not associated with poor prognosis in childhood T-ALL treated in EORTC trials 58 881 and 58 951 (2002)
CAVÉ, H,
SUCIU, S,
PREUDHOMME, C,
Poppe, Bruce,
ROBERT, A,
UYTTEBROEK, A,
...
Long-term results of three randomized trials (58831,58832,58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. (2000)
VILMER, E,
SUCIU, S,
FERSTER, A,
BERTRAND, Y,
CAVÉ, H,
THYSS, A,
...